188 related articles for article (PubMed ID: 9331438)
1. Intranasal mupirocin for outbreaks of methicillin-resistant Staphylococcus aureus.
Bertino JS
Am J Health Syst Pharm; 1997 Oct; 54(19):2185-91. PubMed ID: 9331438
[TBL] [Abstract][Full Text] [Related]
2. A clinical trial of mupirocin in the eradication of methicillin-resistant Staphylococcus aureus nasal carriage in a digestive disease unit.
Dupeyron C; Campillo B; Bordes M; Faubert E; Richardet JP; Mangeney N
J Hosp Infect; 2002 Dec; 52(4):281-7. PubMed ID: 12473473
[TBL] [Abstract][Full Text] [Related]
3. Mupirocin ointment with and without chlorhexidine baths in the eradication of Staphylococcus aureus nasal carriage in nursing home residents.
Watanakunakorn C; Axelson C; Bota B; Stahl C
Am J Infect Control; 1995 Oct; 23(5):306-9. PubMed ID: 8585642
[TBL] [Abstract][Full Text] [Related]
4. [Hospital personnel who are nasal carriers of methicillin-resistant Staphylococcus aureus. Usefulness of treatment with mupirocin].
Gaspar MC; Uribe P; Sánchez P; Coello R; Cruzet F
Enferm Infecc Microbiol Clin; 1992 Feb; 10(2):107-10. PubMed ID: 1643130
[TBL] [Abstract][Full Text] [Related]
5. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment.
Miller MA; Dascal A; Portnoy J; Mendelson J
Infect Control Hosp Epidemiol; 1996 Dec; 17(12):811-3. PubMed ID: 8985769
[TBL] [Abstract][Full Text] [Related]
6. Mupirocin resistance and methicillin-resistant Staphylococcus aureus (MRSA).
Eltringham I
J Hosp Infect; 1997 Jan; 35(1):1-8. PubMed ID: 9032630
[TBL] [Abstract][Full Text] [Related]
7. Control of a methicillin-resistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment.
Hitomi S; Kubota M; Mori N; Baba S; Yano H; Okuzumi K; Kimura S
J Hosp Infect; 2000 Oct; 46(2):123-9. PubMed ID: 11049705
[TBL] [Abstract][Full Text] [Related]
8. Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units.
Muller A; Talon D; Potier A; Belle E; Cappelier G; Bertrand X
Crit Care; 2005 Jun; 9(3):R246-50. PubMed ID: 15987397
[TBL] [Abstract][Full Text] [Related]
9. Targeted intranasal mupirocin to prevent colonization and infection by community-associated methicillin-resistant Staphylococcus aureus strains in soldiers: a cluster randomized controlled trial.
Ellis MW; Griffith ME; Dooley DP; McLean JC; Jorgensen JH; Patterson JE; Davis KA; Hawley JS; Regules JA; Rivard RG; Gray PJ; Ceremuga JM; Dejoseph MA; Hospenthal DR
Antimicrob Agents Chemother; 2007 Oct; 51(10):3591-8. PubMed ID: 17682105
[TBL] [Abstract][Full Text] [Related]
10. The efficacy of intranasal mupirocin in the prevention of staphylococcal infections: a review of recent experience.
Hudson IR
J Hosp Infect; 1994 Jun; 27(2):81-98. PubMed ID: 7930545
[TBL] [Abstract][Full Text] [Related]
11. Can mupirocin prevent methicillin-resistant Staphylococcus aureus infections?
Wertheim HF; Vos MC
Crit Care; 2005 Jun; 9(3):257-8. PubMed ID: 15987417
[TBL] [Abstract][Full Text] [Related]
12. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term-care facility with the use of mupirocin ointment.
Kauffman CA; Terpenning MS; He X; Zarins LT; Ramsey MA; Jorgensen KA; Sottile WS; Bradley SF
Am J Med; 1993 Apr; 94(4):371-8. PubMed ID: 8475930
[TBL] [Abstract][Full Text] [Related]
13. Nasal mupirocin treatment of pharynx-colonized methicillin resistant Staphylococcus aureus: preliminary study with 10 carrier infants.
Hayakawa T; Hayashidera T; Katsura S; Yoneda K; Kusunoki T
Pediatr Int; 2000 Feb; 42(1):67-70. PubMed ID: 10703239
[TBL] [Abstract][Full Text] [Related]
14. Blanket use of intranasal mupirocin for outbreak control and long-term prophylaxis of endemic methicillin-resistant Staphylococcus aureus in an open ward.
Mayall B; Martin R; Keenan AM; Irving L; Leeson P; Lamb K
J Hosp Infect; 1996 Apr; 32(4):257-66. PubMed ID: 8744510
[TBL] [Abstract][Full Text] [Related]
15. Agents for the decolonization of methicillin-resistant Staphylococcus aureus.
McConeghy KW; Mikolich DJ; LaPlante KL
Pharmacotherapy; 2009 Mar; 29(3):263-80. PubMed ID: 19249946
[TBL] [Abstract][Full Text] [Related]
16. Intranasal mupirocin prophylaxis in elective surgery. A review of published studies.
Trautmann M; Stecher J; Hemmer W; Luz K; Panknin HT
Chemotherapy; 2008; 54(1):9-16. PubMed ID: 18063862
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of calcium mupirocin in the eradication of nasal Staphylococcus aureus carriage.
Redhead RJ; Lamb YJ; Rowsell RB
Br J Clin Pract; 1991; 45(4):252-4. PubMed ID: 1810357
[TBL] [Abstract][Full Text] [Related]
18. Mupirocin for controlling methicillin-resistant Staphylococcus aureus: lessons from a decade of use at a university hospital.
Vivoni AM; Santos KR; de-Oliveira MP; Giambiagi-deMarval M; Ferreira AL; Riley LW; Moreira BM
Infect Control Hosp Epidemiol; 2005 Jul; 26(7):662-7. PubMed ID: 16092750
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic rhinosinusitis exacerbations due to methicillin-resistant Staphylococcus aureus with mupirocin irrigations.
Solares CA; Batra PS; Hall GS; Citardi MJ
Am J Otolaryngol; 2006; 27(3):161-5. PubMed ID: 16647979
[TBL] [Abstract][Full Text] [Related]
20. Nasal carriage of meticillin resistant Staphylococcus aureus: the prevalence, patients at risk and the effect of elimination on outcomes among outclinic haemodialysis patients.
Lederer SR; Riedelsdorf G; Schiffl H
Eur J Med Res; 2007 Jul; 12(7):284-8. PubMed ID: 17933699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
